Telomir Pharmaceuticals, Inc.

NASDAQ:TELO
Annual Meeting

of Shareholders

MEETING DATE

09/11/2026
DEF 14A FILED
07/28/2026
PUBLISHED
07/28/2026 9:00 pm
TIME TO PUBLISH
07/30/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:TELO · CUSIP 87975F104 · CLASS common stock, no par value · CIK 0001971532

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of Directors
board
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The Nominating Committee recommended, and the Board approved, the four director nominations.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of Appointment of Independent Registered Public Accounting Firm
auditor
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The Audit Committee discussed Salberg's independence with that firm.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approval of the Adjournment
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

Adjournment would permit further solicitation if votes are insufficient for Proposals 1 or 2.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

66ed99394b2c0a169bc73de4546ab7877d857ea6626f8136e0dea5ffe0dfcae4

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates